Pyrroloquinoline quinone ameliorates oxidative stress and lipid peroxidation in the brain of streptozotocin-induced diabetic mice

Canadian Journal of Physiology and Pharmacology

Volumn 93, Issue 1, 2014, Pages 71-79

  Kumar, Narendra ^a   Kar, Anand ^a  

^a DEVI AHILYA UNIVERSITY   (India)

Author keywords

Antioxidants; Diabetes mellitus; PQQ; TBA RS

Indexed keywords

CHOLESTEROL; GLUCOSE; PYRROLOQUINOLINEQUINONE; TRIACYLGLYCEROL; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN DAMAGE; BRAIN TISSUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BRAIN; CHEMICALLY INDUCED; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN; DIABETES MELLITUS, EXPERIMENTAL; LIPID PEROXIDATION; MALE; MICE; OXIDATIVE STRESS; PQQ COFACTOR; STREPTOZOCIN;

EID: 84920673994     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2014-0270     Document Type: Article

References (96)

1. Abbate, S.L., and Brunzell, J.D. 1990. Pathophysiology of hyperlipidemia in diabetes mellitus. J. Cardiovasc. Pharmacol. 16: 1–7. doi:10.1097/00005344- 199007000-00001. PMID:1696650
2. Aebi, H.E. 1983. Catalase. In Methods in enzymatic analysis. Vol. 3. Edited by H.U. Bergmeyer. Academic Press, New York, N.Y. pp: 276–286
3. Ahmed, D., Kumar, V., Verma, A., Gupta, P.S., Kumar, H., Dhingra, V., et al. 2014. Antidiabetic, renal/hepatic/pancreas/cardiac protective and antioxidant potential of ethanol/dichloromethane extract of Albizzia lebbeck Benth. stem bark (ALEx) on streptozotocin induced diabetic rats. BMC Complement. Altern. Med. 14: 1–17. doi:10.1186/1472-6882-14-243
4. Ahmed, R.G. 2005. The physiological and biochemical effects of diabetes on the balance between oxidative stress and antioxidant defense system. Med. J. Islamic World Acad. Sci. 15: 31–42
5. Aizenman, E., Hartnett, K.A., Zhong, C., Gallop, P.M., and Rosenberg, P.A. 1992. Interaction of the putative essential nutrient pyrroloquinoline quinone with the N-methyl-D-aspartate receptor redox site. J. Neurosci. 12: 2362–2369. PMID:1318959
6. Allain, C.C., Poon, L.S., Chan, C.S.G., Richmond, W., and Fu, P.C. 1974. Enzymatic determination of total serum cholesterol. Clin. Chem. 20: 470–475. PMID: 4818200
7. Andersen, J.K. 2004. Oxidative stress in neurodegeneration: cause or consequence? Nat. Rev. Neurosci. 5: 18–25. doi:10.1038/nrn1434
8. Ansari, M.M., Sreekumar, T.R., Chandra, V., Dubey, P.K., Kumar, G.S., A Amarpal, and Sharma, G.T. 2013. Therapeutic potential of canine bone marrow derived mesenchymal stem cells and its conditioned media in diabetic rat wound healing. Stem Cell Res. Ther. 3: 2–6. doi:10.4172/2157-7633.1000141. PMID: 22264393
9. Armagan, A., Uz, E., Yilmaz, H.R., Soyupek, S., Oksay, T., and Ozcelik, N. 2006. Effects of melatonin on lipid peroxidation and antioxidant enzymes in streptozotocin-induced diabetic rat testis. Asian J. Androl. 8: 595–600. doi:10. 1111/j.1745-7262.2006.00177.x. PMID:16752005
10. Aybek, H., Aybek, Z., Rota, S., Sen, N., and Akbulut, M. 2008. The effects of diabetes mellitus, age, and vitamin E on testicular oxidative stress. Fertil. Steril. 90: 755–760. doi:10.1016/j.fertnstert.2007.01.101. PMID:17482598
11. Bauerly, K., Harris, C., Chowanadisai, W., Graham, J., Havel, P.J., Tchaparian, E., et al. 2011. Altering pyrroloquinoline quinone nutritional status modulates mitochondrial, lipid, and energy metabolism in rats. PLos One, 6: 1–13. doi: 10.1371/journal.pone.0021779. PMID:21814553
12. Baydas, G., Nedzvetskii, V.S., Tuzcu, M., Yasar, A., and Kirichenko, S.V. 2003a. Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. Eur. J. Pharmacol. 462: 67–71. doi:10.1016/S0014-2999(03)01294-9. PMID:12591097
13. Baydas, G., Reiter, R.J., Yasar, A., Tuzcu, M., Akdemir, I., and Nedzvetskii, V.S. 2003b. Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats. Free Radic. Biol. Med. 35: 797–804. doi:10.1016/S0891-5849(03)00408-8. PMID:14583344
14. Bhutada, P., Mundhada, Y., Bansod, K., Tawari, S., Patil, S., Dixit, P., et al. 2011. Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocininduced diabetes. Behav. Brain Res. 220: 30–41. doi:10.1016/j.bbr.2011.01.022. PMID:21262264
15. Biessels, G.J., and Gispen, W.H. 2005. The impact of diabetes on cognition: what can be learned from rodent models? Neurobiol. Aging, 26: 36–41. doi:10.1016/ j.neurobiolaging.2005.08.015. PMID:16223548
16. Biessels, G.J., Kappelle, A.C., Bravenboer, B., Erkelens, D.W., and Gispen, W.H. 1994. Cerebral function in diabetes mellitus. Diabetologia, 37: 643–650. doi: 10.1007/BF00417687. PMID:7958534
17. Biessels, G.J., Van der Heide, L.P., Kamal, A., Bleys, R.L.A.W., and Gispen, W.H. 2002. Ageing and diabetes: implications for brain function. Eur. J. Pharmacol. 441: 1–14. doi:10.1016/S0014-2999(02)01486-3. PMID:12007915
18. Bopanna, K.N., Kannan, J., Sushma, G., Balaraman, R., and Rathod, S.P. 1997. Antidiabetic and antihyperlipaemic effects of neem seed kernel powder on alloxan diabetic rabbits. Indian J. Pharmacol. 29: 162–167
19. Bree, A.J., Puente, E.C., Daphna-Iken, D., and Fisher, S.J. 2009. Diabetes increases brain damage caused by severe hypoglycemia. Am. J. Physiol. Endocrinol. Metab. 297: 194–201. doi:10.1152/ajpendo.91041.2008. PMID:19435850
20. Cardoso, S., Santos, M.S., Seica, R., and Moreira, P.I. 2010. Cortical and hippocampal mitochondria bioenergetics and oxidative status during hyperglycemia and/or insulin-induced hypoglycemia. Biochim. Biophys. Acta, 1802: 942–951. doi:10.1016/j.bbadis.2010.07.001. PMID:20620209
21. Ceretta, L.B., Réus, G.Z., Abelaira, H.M., Ribeiro, K.F., Zappellini, G., Felisbino, F.F., et al. 2012. Increased oxidative stress and imbalance in antioxidant enzymes in the brains of alloxan-induced diabetic rats. Exp. Diabetes Res. 2012: 1–8. doi:10.1155/2012/302682. PMID:22645603
22. Ceriello, A. 2003. New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care, 26: 1589–1596. doi:10.2337/diacare.26.5.1589. PMID:12716823
23. Chaitanya, G.V., Steven, A.J., and Babu, P.P. 2010. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun. Signal. 8: 31–41. doi:10.1186/1478-811X-8-31. PMID:21176168
24. Chowanadisai, W., Bauerly, K.A., Tchaparian, E., Wong, A., Cortopassi, G.A., and Rucker, R.B. 2010. Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1α expression. J. Biol. Chem. 285: 142–152. doi:10.1074/jbc. M109.030130. PMID:19861415
25. Coskun, O., Kanter, M., Korkmaz, A., and Oter, S. 2005. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol. Res. 51: 117–123. doi:10.1016/ j.phrs.2004.06.002. PMID:15629256
26. Ellman, G.L. 1959. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82: 70–77. doi:10.1016/0003-9861(59)90090-6. PMID:13650640
27. Emerit, J., Edeas, M., and Bricaire, F. 2004. Neurodegenerative diseases and oxidative stress. Biomed. Pharmacother. 58: 39–46. doi:10.1016/j.biopha.2003. 11.004. PMID:14739060
28. Fiorentino, T.V., Prioletta, A., Zuo, P., and Folli, F. 2013. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr. Pharm. Des. 19: 5695–5703. doi:10.2174/1381612811319320005. PMID:23448484
29. Fukui, K., Omoi, N.O., Hayasaka, T., Shinnkai, T., Suzuki, S., Abe, K., et al. 2002. Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by vitamin E. Ann. N.Y. Acad. Sci. 959: 275–284. doi:10.1111/j.1749- 6632.2002.tb02099.x. PMID:11976202
30. Gavin, J.R., III, Alberti, K.G.M.M., Davidson, M.B., De Fronzo, R.A., Drash, A., and Gabbe, S.G. 1997. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 20: 1183–1197. PMID: 9203460
31. Griffiths, G., Leverentz, M., Silkowski, H., Gill, N., and Sánchez-Serrano, J.J. 2000. Lipid hydroperoxide levels in plant tissues. J. Exp. Bot. 51: 1363–1370. doi:10. 1093/jexbot/51.349.1363. PMID:10944149
32. Guo, W., Kong, E., and Meydani, M. 2009. Dietary polyphenols, inflammation, and cancer. Nutr. Cancer, 61: 807–810. doi:10.1080/01635580903285098. PMID: 20155620
33. Haces, M.L., Montiel, T., and Massieu, L. 2010. Selective vulnerability of brain regions to oxidative stress in a non-coma model of insulin-induced hypoglycemia. Neuroscience, 165: 28–38. doi:10.1016/j.neuroscience.2009.10.003. PMID: 19818385
34. Haluzik, M., and Nedvidkova, J. 2000. Role of nitric oxide in the development of streptozotocin-induced diabetes mellitus: experimental and clinical implication. Physiol. Res. 49: 37–42. PMID:10984070
35. Hamagishi, Y., Murata, S., Kamei, H., Oki, T., Adachi, O., and Ameyama, M. 1990. New biological properties of PQQ and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema. J. Pharmacol. Exp. Ther. 255: 980–985. PMID:2175808
36. Handschin, C., Rhee, J., Lin, J., Tarr, P.T., and Spiegelman, B.M. 2003. An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc. Natl. Acad. Sci. U.S.A. 100: 7111–7116. doi:10.1073/pnas.1232352100. PMID:12764228
37. Hayashi, K., Kojima, R., and Ito, M. 2006. Strain differences in the diabetogenic activity of streptozotocin in mice. Biol. Pharm. Bull. 29: 1110–1119. doi:10.1248/ bpb.29.1110. PMID:16755002
38. He, K., Nukada, H., Urakami, T., and Murphy, M.P. 2003. Antioxidant and prooxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systems. Biochem. Pharmacol. 65: 67–74. doi:10.1016/ S0006-2952(02)01453-3. PMID:12473380
39. Henquin, J.C. 2004. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes, 49: 1751–1760. doi:10.2337/diabetes.49.11.1751. PMID:11078440
40. Hirao, K., Maruyama, T., Ohno, Y., Hirose, H., Shimada, A., Takei, I., et al. 2010. Association of increased reactive oxygen species production with abdominal obesity in type 2 diabetes. Obes. Res. Clin. Pract. 4: 83–90. doi:10.1016/j.orcp. 2009.09.004. PMID:24345646
41. Jung, S.W., Han, O.K., and Kim, S.J. 2010. Increased expression of β amyloid precursor gene in the hippocampus of streptozotocin-induced diabetic mice with memory deficit and anxiety induction. J. Neural Transm. 117: 1411–1418. doi:10.1007/s00702-010-0516-2. PMID:21069392
42. Kataya, H.A., and Hamza, A.A. 2008. Red cabbage (Brassica oleracea) ameliorates diabetic nephropathy in rats. Evid. Based Complement. Alternat. Med. 5: 281–287. doi:10.1093/ecam/nem029
43. Kuhad, A., and Chopra, K. 2008. Neurobiology of diabetic encephalopathy. Drugs Future, 33: 763–775. doi:10.1358/dof.2008.033.09.1232462
44. Kumar, A., Negi, G., and Sharma, S.S. 2011. JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence. Diabetes Obes. Metab. 13: 750–758. doi:10.1111/j.1463-1326.2011.01402.x. PMID:21447040
45. Kumar, N., and Kar, A. 2013. Regulation of oxidative stress and lipid peroxidation in PTU induced mice, treated with pyrroloquinoline quinone (PQQ). IOSR J. Pharm. Biol. Sci. 8: 23–31. doi:10.9790/3008-0852331
46. Kumar, N., and Kar, A. 2014. Pyrroloquinoline quinine has potential to ameliorate PTU induced lipid peroxidation and oxidative damages in mice. Int. J. Pharm. Pharm. Sci. 6: 880–885
47. Languren, G., Montiel, T., Julio-Amilpas, A., and Massieu, L. 2013. Neuronal damage and cognitive impairment associated with hypoglycemia: an integrated view. Neurochem. Int. 63: 331–343. doi:10.1016/j.neuint.2013.06.018. PMID: 23876631
48. Lapolla, A., Fedele, D., and Traldi, P. 2005. Glyco-oxidation in diabetes and related disease. Clin. Chim. Acta, 2: 236–250. doi:10.1016/j.cccn.2005.03.032. PMID:15939413
49. Lenzen, S. 2008. The mechanisms of alloxan-and streptozotocin-induced diabetes. Diabetologia, 51: 216–226. doi:10.1007/s00125-007-0886-7. PMID:18087688
50. Li, R., Liang, T., Xu, L., Li, Y., Zhang, S., and Duan, X. 2013. Protective effect of cinnamon polyphenols against STZ-diabetic mice fed high-sugar, high-fat diet and its underlying mechanism. Food Chem. Toxicol. 51: 419–425. doi:10. 1016/j.fct.2012.10.024. PMID:23127600
51. Lodovici, M., Bigagli, E., Bardini, G., and Rotella, C.M. 2009. Lipoperoxidation and antioxidant capacity in patients with poorly controlled type 2 diabetes. Toxicol. Ind. Health, 25: 337–341. doi:10.1177/0748233709106464. PMID:19651806
52. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randal, R.J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265–275. PMID: 14907713
53. Magarinos, A.M., and McEwen, B.S. 2000. Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. Proc. Natl. Acad. Sci. U.S.A. 97: 11056–11061. doi:10. 1073/pnas.97.20.11056. PMID:11005876
54. Marklund, S., and Marklund, G. 1974. Involvement of superoxide anion radical in the autoxidation of pyrogallol: A convenient assay for superoxide dismutase. Eur. J. Biochem. 47: 469–474. doi:10.1111/j.1432-1033.1974.tb03714.x. PMID:4215654
55. Mastrocola, R., Restivo, F., Vercellinatto, I., Danni, O., Brignardello, E., Aragno, M., and Boccuzzi, G. 2005. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J. Endocrinol. 187: 37–44. doi:10.1677/joe.1.06269. PMID: 16214939
56. Mathé, D. 1995. Dyslipidemia and diabetes: animal models. Diabetes Metab. 21: 106–111. PMID:7621969
57. Misra, H.S., Rajpurohit, Y.S., and Khairnar, N.P. 2012. Pyrroloquinoline-quinone and its versatile roles in biological processes. J. Biosci. 37: 313–325. doi:10. 1007/s12038-012-9195-5. PMID:22581337
58. Mohandas, J., Marshall, J.J., Duggin, G.G., Horvath, J.S., and Tiller, D.J. 1984. Differential distribution of glutathione and glutathione related enzymes in rabbit kidney: possible interactions in analgesic neuropathy. Biochem. Pharmocol. 33: 1801–1807. doi:10.1016/0006-2952(84)90353-8. PMID:6145422
59. Murugan, P., and Pari, L. 2006. Antioxidant effect of tetrahydrocurcumin in streptozotocin–nicotinamide induced diabetic rats. Life Sci. 79: 1720–1728. doi:10.1016/j.lfs.2006.06.001. PMID:16806281
60. Negi, G., Kumar, A., Kaundal, R.K., Gulati, A., and Sharma, S.S. 2010. Functional and biochemical evidence indicating beneficial effect of melatonin and nicotinamide alone and in combination in experimental diabetic neuropathy. Neuropharmacology, 58: 585–592. doi:10.1016/j.neuropharm.2009.11.018. PMID:20005237
61. Negi, G., Kumar, A., and Sharma, S.S. 2011. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NFkB and Nrf2 cascades. J. Pineal Res. 50: 124–131. doi:10.1111/j.1600-079X.2010. 00821.x. PMID:21062351
62. Northam, E.A., Rankins, D., Lin, A., Wellard, R.M., Pell, G.S., Finch, S.J., et al. 2009. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care, 32: 445–450. doi:10.2337/dc08-1657. PMID: 19151204
63. Nunome, K., Miyazaki, S., Nakano, M., Iguchi-Ariga, S., and Ariga, H. 2008. Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1. Biol. Pharm. Bull. 31: 1321–1326. doi:10.1248/bpb.31.1321. PMID:18591768
64. Ohkawa, H., Ohishi, N., and Yagi, K. 1979. Assay of lipid peroxides in animal tissues by thiobarbiturie acid reaction. Anal. Biochem. 95: 351–358. doi:10. 1016/0003-2697(79)90738-3. PMID:36810
65. Orie, N.N., Zidek, W., and Tepel, M. 1999. Reactive oxygen species in essential hypertension and non-insulin-dependent diabetes mellitus. Am. J. Hypertens. 12: 1169–1174. doi:10.1016/S0895-7061(99)00129-6. PMID:10619578
66. Ouchi, A., Nakano, M., Nagaoka, S., and Mukai, K. 2009. Kinetic study of the antioxidant activity of pyrroloquinolinequinol (PQQH(2), a reduced form of pyrroloquinolinequinone) in micellar solution. J. Agric. Food Chem. 57: 450–456. doi:10.1021/jf802197d. PMID:19108686
67. Ozmen, A., Unek, G., Kipmen-Korgun, D., and Korgun, E.T. 2014. The PI3K/Akt and MAPK-ERK1/2 pathways are altered in STZ induced diabetic rat placentas. Histol. Histopathol. 29: 743–756. PMID:24346807
68. Pitocco, D., Zaccardi, F., Di Stasio, E., Romitelli, F., Santini, S.A., Zuppi, C., and Ghirlanda, G. 2010. Oxidative stress, nitric oxide, and diabetes. Rev. Diabet. Stud. 7: 15–25. doi:10.1900/RDS.2010.7.15
69. Qi, W.W., Zhong, L.Y., Li, X.R., Li, G., Liu, Z.X., Hu, J.F., et al. 2012. Hyperglycemia induces the variations of 11β-hydroxysteroid dehydrogenase type 1 and peroxisome proliferator-activated receptor-γ expression in hippocampus and hypothalamus of diabetic rats. Exp. Diabetes Res. 2012: 107–130. doi:10.1155/ 2012/107130. PMID:22792090
70. Rains, J.L., and Jain, S.K. 2011. Oxidative stress, insulin signaling, and diabetes. Free Radic. Biol. Med. 50: 567–575. doi:10.1016/j.freeradbiomed.2010.12.006. PMID:21163346
71. Rajalingam, R., Srinivasan, N., and Govindarajulu, P. 1993. Effects of alloxan induced diabetes on lipid profiles in renal cortex and medulla of mature albino rats. Indian J. Exp. Biol. 31: 577–579. PMID:8406610
72. Rajpurohit, Y.S., Gopalakrishnan, R., and Misra, H.S. 2008. Involvement of a protein kinase activity inducer in DNA double strand break repair and radioresistance of Deinococcus radiodurans. J. Bacteriol. 190: 3948–3954. doi:10.1128/ JB.00026-08. PMID:18375565
73. Russell, J.W., Berent-Spillson, A., Vincent, A.M., Freimann, C.L., Sullivan, K.A., and Feldman, E.L. 2008. Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiol. Dis. 30: 420–429. doi:10. 1016/j.nbd. 2008.02.013
74. Sepici-Dincel, A., Açikgöz, S., Cevik, C., Sengelen, M., and Yeşilada, E. 2007. Effects of in vivo antioxidant enzyme activities of myrtle oil in normoglycaemic and alloxan diabetic rabbits. J. Ethnopharmacol. 110: 498–503. doi:10. 1016/j.jep.2006.10.015. PMID:17101252
75. Shi, Y., Liang, H., Liu, Y., Ward, W.F., and Remmen, H.V. 2008. PGC-1α plays a protective role against oxidative stress in skeletal muscle. FASEB J. 22: 758
76. Smidt, C.R., Steinberg, F.M., and Rucker, R.B. 1991. Physiologic importance of pyrroloquinoline quinine. Proc. Soc. Exp. Biol. Med. 197: 19–26. doi:10.3181/ 00379727-197-43218. PMID:1850521
77. Srinivasan, K., and Ramarao, P. 2007. Animal models in type 2 diabetes research: an overview. Indian J. Med. Res. 125: 451–472. PMID:17496368
78. Stanely, M.P.P., Kumar, M.R., and Selvakumari, C.J. 2011. Effects of gallic acid on brain lipid peroxide and lipid metabolism in streptozotocin-induced diabetic Wistar rats. J. Biochem. Mol. Toxicol. 25: 101–107. doi:10.1002/jbt.20365. PMID: 20957663
79. Steel, J.H., Terenghi, G., Chung, J.M., Na, H.S., Carlton, S.M., and Polak, J.M. 1994. Increased nitric oxide synthase immunoreactivity in rat dorsal root ganglia in a neuropathic pain model. Neurosci. Lett. 169: 81–84. doi:10.1016/0304- 3940(94)90361-1. PMID:7519340
80. Subash Babu, P., Prabuseenivasan, P., and Ignacimuthu, S. 2007. Cinnamaldehyde a potential antidiabetic agent. Phytomedicine, 14: 15–22. doi:10.1016/j. phymed.2006.11.005. PMID:17140783
81. Szkudelski, T. 2001. The mechanisms of alloxan and streptozotocin action in B cells of rat pancreas. Physiol. Res. 50: 537–546. PMID:11829314
82. Takada, M., Sumi, M., Maeda, A., Watanabe, F., Kamiya, T., Ishii, T., et al. 2012. Pyrroloquinoline quinone, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves impaired glucose tolerance in diabetic KK-Ay mice. Biochem. Biophys. Res. Commun. 428: 315–320. doi:10.1016/j.bbrc.2012.10.055. PMID:23085227
83. Tao, R., Karliner, J.S., Simonis, U., Zheng, J., Zhang, J., Honbo, N., et al. 2007. Pyrroloquinoline quinone preserves mitochondrial function and prevents oxidative injury in adult rat cardiac myocytes. Biochem. Biophys. Res. Commun. 363: 257–262. doi:10.1016/j.bbrc.2007.08.041. PMID:17880922
84. Tomlinson, D.R., and Gardiner, N.J. 2008. Glucose neurotoxicity. Nat. Rev. Neurosci. 9: 36–45. doi:10.1038/nrn2294. PMID:18094705
85. Trinder, P. 1969. Determination of blood glucose using an oxidase–peroxidase system with a non-carcinogenic chromogen. J. Clin. Pathol. 22: 158–161. doi: 10.1136/jcp.22.2.158. PMID:5776547
86. Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T.D., Mazur, M., and Telser, J. 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39: 44–84. doi:10.1016/j.biocel.2006.07.001. PMID:16978905
87. Vijayakumar, M., Govindarajan, R., Rao, G.M.M., Rao, C.V., Shirwaikar, A., Mehrotra, S., and Pushpangadan, P. 2006. Action of Hygrophila auriculata against streptozotocin-induced oxidative stress. J. Ethnopharmacol. 104: 356–361. doi:10.1016/j.jep.2005.09.030. PMID:16289604
88. Wiernsperger, N.F. 2003. Oxidative stress as therapeutic target in diabetes: revisiting the controversy. Diabetes Metab. 29: 579–585. doi:10.1016/S1262- 3636(07)70072-1. PMID:14707886
89. Wojciechowski, P., Juric, D., Louis, X.L., Thandapilly, S.J., Yu, L., Taylor, C., et al. 2010. Resveratrol arrests and regresses the development of pressure overload but not volume overload-induced cardiac hypertrophy in rats. J. Nutr. 140: 962–968. doi:10.3945/jn.109.115006. PMID:20335634
90. Xu, F., Yu, H., Liu, J., and Cheng, L. 2014. Pyrroloquinoline quinone inhibits oxygen/glucose deprivation-induced apoptosis by activating the PI3K/AKT pathway in cardiomyocytes. Mol. Cell. Biochem. 386: 107–115. doi:10.1007/ s11010-013-1849-6. PMID:24114661
91. Young, I.S., and Woodside, J.V. 2001. Antioxidants in health and disease. J. Clin. Pathol. 54: 176–186. doi:10.1136/jcp.54.3.176. PMID:11253127
92. Zhang, L., Liu, J., Cheng, C., Yuan, Y., Yu, B., Shen, A., et al. 2012. The neuroprotective effect of pyrroloquinoline quinone on traumatic brain injury. J. Neurotrauma, 29: 851–864. doi:10.1089/neu.2011.1882. PMID:22040225
93. Zhang, P., Xu, Y., Li, L., Jiang, Q., Wang, M., and Jin, L. 2009. In vitro protective effects of pyrroloquinoline quinone on methylmercury-induced neurotoxicity. Environ. Toxicol. Pharmacol. 27: 103–110. doi:10.1016/j.etap.2008.08.010. PMID:21783927
94. Zhang, Q., Ding, M., Cao, Z., Zhang, J., Ding, F., and Ke, K. 2013. Pyrroloquinoline quinine protects rat brain cortex against acute glutamate-induced neurotoxicity. Neurochem. Res. 38: 1661–1671. doi:10.1007/s11064-013-1068-2. PMID: 23686346
95. Zhang, Y., and Rosenberg, P.A. 2002. The essential nutrient pyrroloquinoline quinone may act as a neuroprotectant by suppressing peroxynitrite formation. Eur. J. Neurosci. 16: 1015–1024. doi:10.1046/j.1460-9568.2002.02169.x. PMID:12383230
96. Zhu, B.Q., Simonis, U., Cecchini, G., Zhou, H.Z., Li, L., Teerlink, J.R., et al. 2006. Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/ reperfusion injury. J. Cardiovasc. Pharmacol. Ther. 11: 119–128. doi:10.1177/ 1074248406288757. PMID:16891289.